Skip to main content
Premium Trial:

Request an Annual Quote

PGXL Joins Generation Health's Best Test Network

Premium

PGXL has been contracted by Generation Health to be part of its Best Test laboratory network, making the Louisville, Ky.-based CLIA-certified lab a preferred station for analyzing samples for clients participating in CVS Caremark's pharmacogenomics testing program.

CVS Caremark earlier this year took a majority stake in the genetic testing benefits management company Generation Health, which is setting up and managing pharmacogenomics testing programs for CVS' clients.

CVS Caremark and Generation Health announced earlier this month 13 drug therapies for which PGx testing will be offered through its personalized medicine program. At the same time, the partners announced the launch of the Best Test Genetics Network, a collection of preferred laboratories that will be conducting genetic testing for clients (PGx Reporter 06/02/10).

Generation Health and PGXL will begin their partnership in July when pharmacogenomics services will be extended to a limited set of CVS Caremark's pharmacy-benefits management clients. In January 2011, Generation Health plans to expand the personalized medicine program, expanding managed diagnostic testing to more clients.

Under the pilot program launching next month, approximately 150,000 eligible members will have the option to sign up for PGx testing through CVS Caremark. In the coming months, the company plans to add clients representing up to a million lives.

CVS Caremark is the largest pharmacy services provider in the country, operating 7,000 CVS/pharmacy and Longs Drugs stores; its Caremark Pharmacy Services division, which includes pharmacy benefit management, mail order, and specialty pharmacy; its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com. Generation Health was founded in 2008 with an aim to drive adoption of genetic tests among employers and payors.

In addition to PGXL, Generation Health has also signed on Clarient to be part of its Best Test network.

TR

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.